The Phibro Animal Health Corporation (NASDAQ:PAHC) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.11-08

There's been a notable change in appetite for Phibro Animal Health Corporation (NASDAQ:PAHC) shares in the week since its first-quarter report, with the stock down 15% to US$32.96. Phibro Animal...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2681828345?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","is_english":true,"pubTime":"2026-11-08 20:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2681828345","market":"hk","top_or_hot":-1,"title":"The Phibro Animal Health Corporation (NASDAQ:PAHC) First-Quarter Results Are Out And Analysts Have Published New Forecasts","media":"Simply Wall St.","content":"<div>\n<p>There's been a notable change in appetite for Phibro Animal Health Corporation (NASDAQ:PAHC) shares in the week since its first-quarter report, with the stock down 15% to US$32.96.       Phibro Animal...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/the-phibro-animal-health-corporation-nasdaqpahc-first-quarte\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Phibro Animal Health Corporation (NASDAQ:PAHC) First-Quarter Results Are Out And Analysts Have Published New Forecasts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Phibro Animal Health Corporation (NASDAQ:PAHC) First-Quarter Results Are Out And Analysts Have Published New Forecasts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-11-08 20:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/the-phibro-animal-health-corporation-nasdaqpahc-first-quarte><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There's been a notable change in appetite for Phibro Animal Health Corporation (NASDAQ:PAHC) shares in the week since its first-quarter report, with the stock down 15% to US$32.96.       Phibro Animal...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/the-phibro-animal-health-corporation-nasdaqpahc-first-quarte\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QID","symbol_name":"两倍做空纳斯达克指数ETF-ProShares","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/the-phibro-animal-health-corporation-nasdaqpahc-first-quarte","article_id":"2681828345","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/the-phibro-animal-health-corporation-nasdaqpahc-first-quarte","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2681828345","pubTimestamp":1794142107,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"SSimply Wall StNovember 8, 2026","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"QID":"两倍做空纳斯达克指数ETF-ProShares","QQQE":"Direxion NASDAQ-100 Equal Weighted Index ETF","FEBU":"AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF","QQQY":"Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF","VGFPF":"Vanguard Funds PLC","TQQQ":"纳指三倍做多ETF","JOYT":"JPMorgan Equity and Options Total Return ETF","03086":"华夏纳指","TQQY":"GraniteShares YieldBOOST QQQ ETF","QDTE":"Roundhill Nasdaq-100 0DTE Covered Call Strategy ETF","QYLG":"Nasdaq 100 Covered Call & Growth ETF","PMDE":"PGIM S&P 500 Max Buffer ETF - December","GPIQ":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","RGLO":"Global Equity Active ETF","QQQJ":"Invesco NASDAQ Next Gen 100 ETF","GXDW":"Global X Dorsey Wright Thematic ETF","TECS":"Direxion Daily Technology Bear 3X ETF","QQQM":"NASDAQ100指数ETF-Invesco","JEPQ":"JPMorgan Nasdaq Equity Premium Income ETF","SQQQ":"纳指三倍做空ETF","IYW":"美国科技ETF-iShares","PSQ":"做空纳斯达克100指数ETF-ProShares",".IXIC":"NASDAQ Composite","NDX":"纳斯达克100指数","QQQ":"纳指100ETF","BK4007":"制药","QQQA":"ProShares Nasdaq-100 Dorsey Wright Momentum ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","VOTE":"TCW Transform 500 ETF","FTEC":"Fidelity MSCI Information Techno","ONEQ":"Fidelity NASDAQ Composite Index ETF","DECU":"AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF","PAHC":"Phibro Animal Health Corporation"},"translate_title":"Phibro 动物保健公司（纳斯达克股票代码：PAHC）第一季度业绩公布，分析师发布了新的预测","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/8dabc4e8eef403611fa7f110e6758498","symbols_score_info":{"JEPQ":0.6,"QID":0.6,"FEBU":0.9,"QDTE":0.6,"QQQJ":0.6,"PAHC":1.5,"QQQY":0.6,"PSQ":0.6,"QYLG":0.6,"VGFPF":0.9,"GXDW":0.9,"JOYT":0.9,"PMDE":0.9,"QQQA":0.6,"TECS":0.6,"SQQQ":0.6,"QQQM":0.6,"GPIQ":0.6,"FTEC":0.6,"RGLO":0.9,"ONEQ":0.6,"TQQY":0.6,"QLD":0.6,"TQQQ":0.6,"NDX":0.6,"MNQmain":0.6,"QQQE":0.6,"03086":0.6,"DECU":0.9,"QQQ":0.6,".IXIC":1.5,"IYW":0.6,"NQmain":0.6,"VOTE":0.9},"content_text":"There's been a notable change in appetite for Phibro Animal Health Corporation (NASDAQ:PAHC) shares in the week since its first-quarter report, with the stock down 15% to US$32.96.       Phibro Animal Health reported in line with analyst predictions, delivering revenues of US$387m and statutory earnings per share of US$2.43, suggesting the business is executing well and in line with its plan.     Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual.  Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Phibro Animal Health after the latest results.  This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.NasdaqGM:PAHC Earnings and Revenue Growth November 8th 2026 Taking into account the latest results, the consensus forecast from Phibro Animal Health's three analysts is for revenues of US$1.58b in 2027. This reflects a reasonable 2.4% improvement in revenue compared to the last 12 months.       Statutory earnings per share are predicted to leap 22% to US$3.09.        Yet prior to the latest earnings, the analysts had been anticipated revenues of US$1.58b and earnings per share (EPS) of US$2.92 in 2027.        The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates.     View our latest analysis for Phibro Animal Health   There's been no major changes to the consensus price target of US$47.00, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation.        It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean.  Currently, the most bullish analyst values Phibro Animal Health at US$55.00 per share, while the most bearish prices it at US$37.00.   Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Phibro Animal Health shareholders.      These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Phibro Animal Health's past performance and to peers in the same industry. It's pretty clear that there is an expectation that Phibro Animal Health's revenue growth will slow down substantially, with revenues to the end of 2027 expected to display 3.2% growth on an annualised basis. This is compared to a historical growth rate of 12% over the past five years.    Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 8.5% annually.  Factoring in the forecast slowdown in growth, it seems obvious that Phibro Animal Health is also expected to grow slower than other industry participants.     AdvertisementThe Bottom Line  The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Phibro Animal Health's earnings potential next year.        On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry.       There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.   Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings.   At Simply Wall St, we have a full range of analyst estimates for Phibro Animal Health going out to 2029, and you can see them free on our platform here..  We don't want to rain on the parade too much, but we did also find 1 warning sign for Phibro Animal Health that you need to be mindful of.  New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2681828345","isCrawlerRequest":true}